These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase. Nguyen C; Ruda GF; Schipani A; Kasinathan G; Leal I; Musso-Buendia A; Kaiser M; Brun R; Ruiz-Pérez LM; Sahlberg BL; Johansson NG; Gonzalez-Pacanowska D; Gilbert IH J Med Chem; 2006 Jul; 49(14):4183-95. PubMed ID: 16821778 [TBL] [Abstract][Full Text] [Related]
48. Uracil derivatives. III. Synthesis and growth-inhibitory activity against L-1210 cells of 5,6-disubstituted uracils. Okada J; Nakano K; Miyake H; Yasufuku S Chem Pharm Bull (Tokyo); 1982 Jan; 30(1):91-6. PubMed ID: 7083416 [No Abstract] [Full Text] [Related]
49. New glycosyl-(carboxamide)-1,2,3-triazole-N-nucleosides: synthesis and antitumor activity. Al-Masoud NA; Al-Soud YA Nucleosides Nucleotides Nucleic Acids; 2002; 21(4-5):361-75. PubMed ID: 12182348 [TBL] [Abstract][Full Text] [Related]
50. Synthesis of acyclo-C-nucleosides in the imidazo[1,2-a]pyridine and pyrimidine series as antiviral agents. Gueiffier A; Lhassani M; Elhakmaoui A; Snoeck R; Andrei G; Chavignon O; Teulade JC; Kerbal A; Essassi EM; Debouzy JC; Witvrouw M; Blache Y; Balzarini J; De Clercq E; Chapat JP J Med Chem; 1996 Jul; 39(14):2856-9. PubMed ID: 8709116 [TBL] [Abstract][Full Text] [Related]
51. New Derivatives of 5-Substituted Uracils: Potential Agents with a Wide Spectrum of Biological Activity. Kezin VA; Matyugina ES; Novikov MS; Chizhov AO; Snoeck R; Andrei G; Kochetkov SN; Khandazhinskaya AL Molecules; 2022 Apr; 27(9):. PubMed ID: 35566215 [TBL] [Abstract][Full Text] [Related]
52. Anticancer activity of new (tetrazol-5-yl)methylindole derivatives and their acyclic c-nucleoside analogs. El-Sayed WA; El-Kosy SM; Ali OM; Emselm HM; Abdel-Rahman AA Acta Pol Pharm; 2012; 69(4):669-77. PubMed ID: 22876609 [TBL] [Abstract][Full Text] [Related]
53. Novel acyclic amide-conjugated nucleosides and their analogues. Boncel S; Walczak K Nucleosides Nucleotides Nucleic Acids; 2009 Feb; 28(2):103-17. PubMed ID: 19219740 [TBL] [Abstract][Full Text] [Related]
54. Synthesis and anticancer activity of 5'-phthaloylnucleosides. Orzeszko A; Vilpo J; Vilpo L; Kamińska B Pharmazie; 2003 Mar; 58(3):169-72. PubMed ID: 12685810 [TBL] [Abstract][Full Text] [Related]
55. Design, synthesis and cytotoxicity of a new series of isoxazolidine based nucleoside analogues. Piotrowska DG; Cieślak M; Królewska K; Wróblewski AE Arch Pharm (Weinheim); 2011 May; 344(5):301-10. PubMed ID: 21312233 [TBL] [Abstract][Full Text] [Related]
56. Nucleosides and nucleotides. 175. Structural requirements of the sugar moiety for the antitumor activities of new nucleoside antimetabolites, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and -uracil1. Hattori H; Nozawa E; Iino T; Yoshimura Y; Shuto S; Shimamoto Y; Nomura M; Fukushima M; Tanaka M; Sasaki T; Matsuda A J Med Chem; 1998 Jul; 41(15):2892-902. PubMed ID: 9667977 [TBL] [Abstract][Full Text] [Related]
57. Synthesis and biological evaluation of 2,6-dichloropurine bicyclonucleosides containing a triazolyl-carbohydrate moiety. Zhang Q; He P; Zhou G; Gu Y; Fu T; Xue D; Liu HM Carbohydr Res; 2013 Dec; 382():65-70. PubMed ID: 24211367 [TBL] [Abstract][Full Text] [Related]
58. Synthesis and biological properties of 5-(1H-1,2,3-triazol-4-yl)isoxazolidines: a new class of C-nucleosides. Giofrè SV; Romeo R; Carnovale C; Mancuso R; Cirmi S; Navarra M; Garozzo A; Chiacchio MA Molecules; 2015 Mar; 20(4):5260-75. PubMed ID: 25812148 [TBL] [Abstract][Full Text] [Related]